Identification of Non-responders to Levothyroxine Therapy

NCT03627611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Hypothyroidism
Biomarkers
Endocrine System Diseases

Interventions

DRUG: Levothyroxin
DRUG: Liothyronine

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]